Clinical Trials Browser

Phase 2/3 × Gestational Trophoblastic Disease × Letrozole × Clear all

NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Phase 2/3 Unknown

Hydatidiform Mole, Gestational Trophoblastic Disease